Angioplasty Catheters Market
Angioplasty Catheters Market
$4,750.00
This comprehensive medical market and technology report provides an overview and in-depth market analysis of angioplasty catheters, specifically plain old balloon angioplasty (POBA), drug-coated balloon (DCB), cutting balloon, and scoring balloon catheters, used in the treatment of severe coronary artery disease (CAD) and peripheral artery disease (PAD).
Publisher: Meddevicetracker
- Description
- Contents
Overview
The global market for angioplasty catheters is being driven by the increasing prevalence of cardiovascular disease (CVD). CVD is the leading cause of death globally, responsible for over 17 million deaths annually. This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the global angioplasty catheter products market, which includes plain old balloon angioplasty (POBA), drug-coated balloon (DCB), cutting balloon, and scoring balloon angioplasty catheters. Primary research querying interventional cardiologists regarding device preferences and angioplasty utilization was leveraged in the formulation of this report’s forecasts and analyses. Global product sales are projected to expand at a compound annual growth rate (CAGR) of 3.6% during 2016-21, increasing from approximately $1,890m in 2016 to an estimated $2,259.8m in 2021. Countries/regions covered by this report include the US, five major European markets (France, Germany, Italy, Spain, and the UK), Japan, and the Rest of the World segment (which combines estimated sales data for all other countries).
TABLE OF CONTENTS
EXECUTIVE SUMMARY …………………………………………………………………………. ES-1
i. Cardiovascular diseases overview …………………………………………. ES-1
ii. Global angioplasty catheters market ………………………………………. ES-1
a. Market drivers and limiters ……………………………………… ES-3
b. Device segment insights…………………………………………. ES-4
c. Technology trends …………………………………………………. ES-5
d. Market leaders ………………………………………………………. ES-6
e. Competitive strategies ……………………………………………. ES-6
f. Emerging competition …………………………………………….. ES-7
iii. Methodology ……………………………………………………………………….. ES-7
Exhibit ES-1: Angioplasty catheters global market forecast, 2016-21 ……………. ES-2
Exhibit ES-2: Global angioplasty catheters market, share by country/region, 2016 ………………………………………………………….. ES-3
Exhibit ES-3: Drivers and limiters of growth on the angioplasty catheters market ……………………………………………………………….. ES-4
1. CARDIOVASCULAR DISEASES OVERVIEW …………………………………….. 1-1
1.1 Acute coronary syndrome ………………………………………………………… 1-3
1.1.1 Atherosclerosis ………………………………………………………… 1-4
1.1.2 Angina pectoris ………………………………………………………… 1-5
1.1.3 Myocardial infarction ………………………………………………… 1-6
1.1.4 Diagnosis and treatment………………………………………….. 1-10
1.2 Hypertension ……………………………………………………………………….. 1-10
1.3 Peripheral vascular disease …………………………………………………… 1-13
1.3.1 Critical limb ischemia ………………………………………………. 1-14
1.3.2 Aneurysm ……………………………………………………………… 1-14
1.3.3 Deep vein thrombosis/pulmonary embolism ……………….. 1-15
1.3.4 Diagnosis and treatment………………………………………….. 1-17
1.4 Cerebrovascular disease ……………………………………………………….. 1-18
1.4.1 Diagnosis and treatment………………………………………….. 1-21
1.5 Bibliography …………………………………………………………………………. 1-22
Exhibit 1-1: Estimated mortality due to ischemic heart disease and cerebrovascular disease, select countries ………………………………….. 1-1
Exhibit 1-2: Top 10 countries with the highest CVD death rates……………………… 1-2
Exhibit 1-3: Estimated incident cases for acute coronary syndrome, select countries ……………………………………………………………………… 1-4
Exhibit 1-4: Age-standardized incidence (000s) of angina pectoris, select regions ………………………………………………………………………… 1-6
Exhibit 1-5: Clinical classification of acute myocardial infarction ……………………. 1-7
Exhibit 1-6: Age-standardized incidence (000s) of acute myocardial infarction, select regions ………………………………………………………….. 1-9
Exhibit 1-7: Estimated incident cases of myocardial infarction, select countries .. 1-9
Exhibit 1-8: Estimated prevalent cases of hypertension, select countries ………. 1-12
Exhibit 1-9: Mortality attributable to hypertensive diseases, select countries ….. 1-12
Exhibit 1-10: Estimated incident cases of DVT, select countries …………………….. 1-16
Exhibit 1-11: Estimated incident cases of PE, select countries ………………………. 1-17
Exhibit 1-12: Estimated incident cases of stroke, select countries ………………….. 1-20
Exhibit 1-13: Estimated prevalent cases of stroke, select countries ………………… 1-20
2. ANGIOPLASTY CATHETER PRODUCTS ………………………………………….. 2-1
2.1 Balloon angioplasty ………………………………………………………………… 2-1
2.1.1 Conventional balloon catheter products ………………………. 2-4
2.1.2 Drug-coated balloon catheter products ……………………….. 2-4
2.1.3 Drug-coated balloon catheters in development …………….. 2-7
2.1.4 Cutting balloon catheter products ……………………………… 2-12
2.1.5 Scoring balloon catheter products …………………………….. 2-15
2.2 Emerging technology …………………………………………………………….. 2-17
2.3 Bibliography …………………………………………………………………………. 2-19
Exhibit 2-1: Advantages and disadvantages of balloon angioplasty…………………. 2-2
Exhibit 2-2: Clinical requirements of balloon catheters ………………………………….. 2-2
Exhibit 2-3: Advantages and disadvantages of OTW and RX balloon catheters … 2-3
Exhibit 2-4: Select images of balloon angioplasty catheters …………………………… 2-5
Exhibit 2-5: Select balloon catheters and manufacturers ……………………………….. 2-6
Exhibit 2-6: Select images of DCB catheters ……………………………………………….. 2-8
Exhibit 2-7: Select drug-coated balloon catheters and manufacturers ……………… 2-9
Exhibit 2-8: Current clinical trials investigating drug-coated balloon catheters …. 2-10
Exhibit 2-9: Select images of cutting balloon catheters ………………………………… 2-14
Exhibit 2-10: Select images of scoring balloon catheters ……………………………… 2-16
3. ANGIOPLASTY CATHETER PRODUCTS MARKET …………………………… 3-1
3.1 Global market insights …………………………………………………………….. 3-1
3.1.1 Market value ……………………………………………………………. 3-2
3.1.2 Technology trends ……………………………………………………. 3-9
3.1.3 Market drivers and limiters ………………………………………. 3-10
3.1.4 Angioplasty catheters overview ………………………………… 3-12
3.1.5 Market leaders ……………………………………………………….. 3-14
3.1.6 Competitive strategies …………………………………………….. 3-15
3.1.7 Emerging competition ……………………………………………… 3-15
3.2 Global competitors ………………………………………………………………… 3-16
3.2.1 Balloon angioplasty catheters …………………………………… 3-16
3.2.2 Drug-coated balloon angioplasty catheters ………………… 3-17
3.2.3 Cutting balloon angioplasty catheters ………………………… 3-19
3.2.4 Scoring balloon angioplasty catheters ……………………….. 3-20
3.3 Market forecast …………………………………………………………………….. 3-21
3.3.1 Market forecast: US ………………………………………………… 3-21
3.3.2 Market forecast: five major EU markets ……………………… 3-33
3.3.3 Market forecast: Japan ……………………………………………. 3-51
3.3.4 Market forecast: RoW ……………………………………………… 3-62
3.4 Bibliography …………………………………………………………………………. 3-74
Exhibit 3-1: Angioplasty catheters, global market forecast, 2016-21 ………………… 3-3
Exhibit 3-2: Angioplasty catheter sales combined market forecast ($m), by product segment, 2016-21 …………………………………………………… 3-4
Exhibit 3-3: Global angioplasty catheters market, share by country/region, 2016 …………………………………………………………… 3-6
Exhibit 3-4: Global angioplasty catheter sales combined market forecast ($m), by country/region, 2016-21 ………………………………………………………. 3-7
Exhibit 3-5: Drivers and limiters of growth on the angioplasty catheters market …………………………………………………………………… 3-12
Exhibit 3-6: Average sale price of selected angioplasty catheters in 2017 ………. 3-13
Exhibit 3-7: Global POBA catheters market, share by supplier, 2016 …………….. 3-17
Exhibit 3-8: Global DCB catheters market, share by supplier, 2016 ………………. 3-19
Exhibit 3-9: Global scoring balloon catheters market, share by supplier, 2016 … 3-20
Exhibit 3-10: US angioplasty procedure volumes forecast (000s), 2016-21 …….. 3-23
Exhibit 3-11: US angioplasty catheter sales combined market forecast ($m), by product segment, 2016-21………………………………………………… 3-25
Exhibit 3-12: US POBA catheters market forecast, 2016-21 …………………………. 3-27
Exhibit 3-13: US POBA catheters market, share by supplier, 2016 ……………….. 3-28
Exhibit 3-14: US DCB catheters market forecast, 2016-21 …………………………… 3-29
Exhibit 3-15: US DCB catheters market, share by supplier, 2016 ………………….. 3-30
Exhibit 3-16: US cutting balloon catheters market forecast, 2016-21 ……………… 3-31
Exhibit 3-17: US scoring balloon catheters market forecast, 2016-21 …………….. 3-32
Exhibit 3-18: US scoring balloon catheters market, share by supplier, 2016 …… 3-33
Exhibit 3-19: Five major EU markets PTCA procedure volumes forecast (000s), 2016-21 ………………………………………………………. 3-36
Exhibit 3-20: Five major EU markets PTA procedure volumes forecast (000s), 2016-21 ………………………………………………………. 3-38
Exhibit 3-21: Five major EU markets angioplasty catheter sales combined market forecast ($m), by product segment, 2016-21 …………………. 3-41
Exhibit 3-22: Five major EU markets POBA catheters market forecast, 2016-21 ……………………………………………………… 3-43
Exhibit 3-23: Five major EU markets POBA catheters market, share by supplier, 2016 …………………………………………………………………. 3-44
Exhibit 3-24: Five major EU markets DCB catheters market forecast, 2016-21 .. 3-45
Exhibit 3-25: Five major EU markets DCB catheters market, share by supplier, 2016 …………………………………………………………………. 3-47
Exhibit 3-26: Five major EU markets cutting balloon catheters market forecast, 2016-21 ……………………………………………………… 3-48
Exhibit 3-27: Five major EU markets scoring balloon catheters market forecast, 2016-21 ……………………………………………………… 3-50
Exhibit 3-28: Five major EU markets scoring balloon catheters market, share by supplier, 2016 ………………………………………………………… 3-51
Exhibit 3-29: Japan angioplasty catheter sales combined market forecast ($m), by product segment, 2016-21………………………………………………… 3-52
Exhibit 3-30: Japanese PCI procedure volumes forecast, 2016-21 ……………….. 3-54
Exhibit 3-31: Japan POBA catheters market forecast, 2016-21 …………………….. 3-56
Exhibit 3-32: Japan POBA catheters market, share by supplier, 2016 ……………. 3-57
Exhibit 3-33: Japan DCB catheters market forecast, 2016-21 ………………………. 3-58
Exhibit 3-34: Japan cutting balloon catheters market forecast, 2016-21 …………. 3-59
Exhibit 3-35: Japan scoring balloon catheters market forecast, 2016-21 ………… 3-61
Exhibit 3-36: Japan scoring balloon catheters market, share by supplier, 2016 …………………………………………………………………. 3-62
Exhibit 3-37: RoW angioplasty catheter sales combined market forecast ($m), by product segment, 2016-21 …………………………… 3-63
Exhibit 3-38: RoW POBA catheters market forecast, 2016-21 ………………………. 3-67
Exhibit 3-39: RoW POBA catheters market, share by supplier, 2016 …………….. 3-68
Exhibit 3-40: RoW DCB catheters market forecast, 2016-21 ………………………… 3-69
Exhibit 3-41: RoW DCB catheters market, share by supplier, 2016 ……………….. 3-70
Exhibit 3-42: RoW cutting balloon catheters market forecast, 2016-21 …………… 3-71
Exhibit 3-43: RoW Scoring balloon catheters market forecast, 2016-21 …………. 3-72
Exhibit 3-44: RoW scoring balloon catheters market, share by supplier, 2016 …………………………………………………………………. 3-73
APPENDIX: COMPANY LISTING ……………………………………………………………… A-1
© Pharma Intelligence UK Ltd. This document is a licensed product and is not to be reproduced or redistributed
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com for further help or assistance.
Telehealth, Wearables and Apps – Report 1 
Sign up to the